Martingale Asset Management’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $830K | Buy |
+71,702
| New | +$830K | 0.02% | 510 |
|
|
2023
Q2 | – | Sell |
-11,921
| Closed | -$665K | – | 874 |
|
|
2023
Q1 | $665K | Buy |
11,921
+3
| +0% | +$167 | 0.01% | 549 |
|
|
2022
Q4 | $434K | Buy |
11,918
+3,314
| +39% | +$121K | 0.01% | 646 |
|
|
2022
Q3 | $246K | Buy |
+8,604
| New | +$246K | ﹤0.01% | 747 |
|
|
2021
Q2 | – | Sell |
-23,019
| Closed | -$4.17M | – | 901 |
|
|
2021
Q1 | $4.17M | Sell |
23,019
-21,613
| -48% | -$3.91M | 0.05% | 207 |
|
|
2020
Q4 | $6.32M | Buy |
+44,632
| New | +$6.32M | 0.07% | 207 |
|